Cutaneous leishmaniasis;Kutane Leishmaniose

Hautarzt

Volumn 54, Issue 6, 2003, Pages 506-512

  Enk, C D ^a,b   Gardlo, K ^c   Hochberg, M ^a   Ingber, A ^a   Ruzicka, T ^c  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NONE

Author keywords

Cutaneous leishmaniasis; Diagnosis; Epidemiology; Treatment

Indexed keywords

AMPHOTERICIN B; ANTIMONY DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

ARTICLE; DRUG FORMULATION; FREEZING; HUMAN; HYPERTHERMIC THERAPY; INCIDENCE; INFECTION RISK; LEISHMANIA; LEISHMANIASIS; MACROPHAGE ACTIVATION; MUCOSA; NONHUMAN; PARASITE TRANSMISSION; PHOTODYNAMIC THERAPY; PROTOZOAL INFECTION; PSYCHODIDAE; SKIN INFECTION; SKIN ULCER; SMEAR; VACCINE PRODUCTION;

EID: 0038068937     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0530-5     Document Type: Article

References (40)

1. Alvar J, Canavate C, Gutierrez-Solar B et al. (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10:298-319
2. Ashford RW (1997) The leishmaniasis as model zoonoses. Ann Trop Med Parasitol 91:693-701
3. Bahamdan KA, Tallab TM, Johargi H et al. (1997) Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. Int J Dermatol 36:59-60
4. Bassiouny A, Meshad M, Tallaat M (1982) Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 107:467-474
5. Bryceson A (1987) Therapy in man. In: Peters W, Killick-Kendrick R (eds) The leishmaniases in biology and medicine. Vol II: Clinical aspects and control. Academic Press, London, pp 847-895
6. Davidson RN (1997) AIDS and leishmaniasis. Genitourin Med 73:237-239
7. Davidson RN (1998) Practical guide for the treatment of Leishmaniasis. Drugs 56:1009-1018
8. Desjeux P (1996) Leishmaniasis: public health aspects and control. Clin Dermatol 14:417-423
9. Dogra J, Aneja N, Lal BB, Mishra SN (1990) Cutaneous leishmaniasis in India: Clinical experience with itraconazole (R51 211 Janssen). Int J Dermatol 29:661-662
10. El-On J, Halevy S, Grunwald MH (1992) Topical treatment of Old World Leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 27:227-231
11. Enk CD, Fritsch C, Jonas F et al. (in press) Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 139
12. Evans D (1989) Handbook on isolation, characterization and cryopreservation of Leishmaniasis. Geneva: UNDP/World Bank/WHO (TDR)
13. Faris RM, Jarallah JS, Khoja TA, Al Yamani MJ (1993) Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 32:610-612
14. Grevenik SA, Lerner EA (1996) Leishmaniasis. J Am Acad Dermatol 34:257-277
15. Handman E (2001) Leisbmaniasis: current status of vaccine development. Clin Microbiol Rev 14:229-243
16. Hepburn NC (2000) Cutaneous leishmaniasis. Br J Dermatol 25:363-370
17. Hepburn NC, Tidman MJ, Hunter JAA (1993) Cutaneous Leishmaniasis in British troops from Belize. Br J Dermatol 128:63-68
18. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191-1199
19. Herwaldt BL, Arena FE, Navin TR (1992) The natural history of cutaneous leishmaniasis in Guatemala. J Infec Dis 165:518-527
20. Herwaldt BL, Berman JD (1992) Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306
21. Jha TK, Olliaro P, Thakur CPN et al. (1998) Randomised controlled trial of aminosidine (paromomycin) v sodium stiboglucanate for treating visceral leishmaniasis in North Bihar, India. Br Med J 316:1200-1205
22. Kilgour V, Gardener PJ, Godfrey DG, Peters W (1974) Demonstration of electrophoretic variation of two aminotransferases in Leishmaniasis. Ann Trop Med Parasitol 68:245-246
23. Kubba R, El-Hassan AM, Al-Gindan Y et al. (1987) Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Derm 16:1183-1189
24. Lang K, Enk CD, Horska Z et al. (in press) Effective treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol
25. Lerner EA, Ribeiro JMC, Nelson JR, Lerner MR (1991) Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem 266:11214-11236
26. Levine N (1992) Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol 128:759-761
27. McMahon-Pratt D, Bennet E, David JR (1982) Monoclonal antibodies that distinguish subspecies of Leishmaniasis braziliensis. J Immunol 129:926-927
28. Melby PC (2002) Vaccination against cutaneous leishmaniasis. Am J Clin Dermatol 3:557-570
29. Navin TR, Arana BA, Arana FE et al. (1992) Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165:528-534
30. Norton SA, Frankenburg S, Klaus SN (1992) Cutaneous leishmaniasis aquired during military service in the Middle East. Arch Dermatol 128:83-87
31. Rashid JR, Chunge CN, Oster CE et al. (1986) Post kalaazar dermal leishmaniasis occurring after long cure of visceral leishmaniasis in Kenya. E Afr Med J 64:365-371
32. Rogers KA, DeKrey GK, Mbow ML et al. (2002) Type 1 and type 2 responses to leishmania major. FEMS Microbiol Lett 209:1-7
33. Saenz RE, Paz H, Berman JD (1990) Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 89:147-155
34. Saldanta AC, Romeo GA, Merchan-Haman E et al. (1999) A comparative study between sodium stibogluconate BP 88R and Meglumine atimoniate in the treatment of cutaneous leishmaniasis: the efficacy and safety. Rev Soc Bras Med Trop 32:383-387
35. Saravia NG, Weigle K, Segura I et al. (1990) Recurrent lesions in human Leishmania braziliensis infection: reactivation or reinfection? Lancet 336:398-402
36. Schalling HDFH, Oskam L (2000) Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Trop Med Int Health 7:641-651
37. Schnur LF, Jacobson RL (1987) Parasitological techniques in the Leishmaniases. Vol 1. Academic Press, London, p 499
38. Shaw JJ (1994) Taxonomy of the genus Leishmaniais: present and future trends and their implications. Mem Inst Osealdo Cruz 89:471-478
39. Weigle KA, Valderrama L, Arias A et al. (1991) Leishmanin standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg 44:260-271
40. WHO (1994) Report on the consultative meeting on Leishmania/HIV co-infection, Rome, 6-7 September, Geneva: WHO; WHO/LEIS/95.35/1995